Evidence map›Paper›PMID 28181348›Full record

ArticleJournal of magnetic resonance imaging : JMRI2017

Can algorithmically assessed MRI features predict which patients with a preoperative diagnosis of ductal carcinoma in situ are upstaged to invasive breast cancer?

Michael R Harowicz, Ashirbani Saha, Lars J Grimm, P Kelly Marcom, Jeffrey R Marks, E Shelley Hwang, Maciej A Mazurowski

Open access · greenAbstract read
In one paragraph

Article in Journal of magnetic resonance imaging : JMRI, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Predictive Performance of Radiomic Features Extracted from Breast MR Imaging in Postoperative Upgrading of Ductal Carcinoma in Situ to Invasive Carcinoma.Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine · 2025
    Article
  5. Article
  6. New Frontiers in Breast Cancer Imaging: The Rise of AI.Bioengineering (Basel, Switzerland) · 2024
    Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Machine learning in breast MRI.Journal of magnetic resonance imaging : JMRI · 2020
    Review
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Michael R HarowiczDepartment of Radiology, Duke University School of Medicine, Duke University, Durham, North Carolina, USA.ORCID 0000-0002-8002-5210
Ashirbani SahaDepartment of Radiology, Duke University School of Medicine, Duke University, Durham, North Carolina, USA.
Lars J GrimmDepartment of Radiology, Duke University School of Medicine, Duke University, Durham, North Carolina, USA.
P Kelly MarcomDepartment of Medicine, Duke University School of Medicine, Durham, North Carolina, USA.
Jeffrey R MarksDepartment of Surgery, Duke University School of Medicine, Durham, North Carolina, USA.
E Shelley HwangDepartment of Surgical Oncology, Duke University Medical Center, Durham, North Carolina, USA.
Maciej A MazurowskiDepartment of Radiology, Duke University School of Medicine, Duke University, Durham, North Carolina, USA.
Duke University · USDuke Medical Center · US

Funding

Breast Cancer Detection ConsortiumU01CA214183 · NCI · DUKE UNIVERSITY · PI MARKS, JEFFREY R., TANG, CHA-MEI · 2016 to 2021
$2.4M
Machine learning and collaborative filtering tools for personalized education in digital breast tomosynthesisR01EB021360 · NIBIB · DUKE UNIVERSITY · PI MAZUROWSKI, MACIEJ A. · 2016 to 2019
$1.6M
NCI NIH HHS U01 CA214183NIBIB NIH HHS R01 EB021360
6 · The paper itself

Abstract

purposeTo assess the ability of algorithmically assessed magnetic resonance imaging (MRI) features to predict the likelihood of upstaging to invasive cancer in newly diagnosed ductal carcinoma in situ (DCIS). MATERIALS AND

methodsWe identified 131 patients at our institution from 2000-2014 with a core needle biopsy-confirmed diagnosis of pure DCIS, a 1.5 or 3T preoperative bilateral breast MRI with nonfat-saturated T

resultsThe rate of upstaging of DCIS to invasive cancer in our study was 26.7% (35/131). Out of all imaging variables tested, the information measure of correlation 1, which quantifies spatial dependency in neighboring voxels of the tumor, showed the highest predictive value of upstaging with an area under the curve (AUC) = 0.719 (95% confidence interval [CI]: 0.609-0.829). This feature was statistically significant after adjusting for tumor size (P < 0.001).

conclusionAutomatically assessed MRI features may have a role in triaging which patients with a preoperative diagnosis of DCIS are at highest risk for occult invasive disease. LEVEL OF EVIDENCE: 4 Technical Efficacy: Stage 3 J. Magn. Reson. Imaging 2017;46:1332-1340.

Indexed as

Magnetic Resonance ImagingAdultAgedAged, 80 and overAlgorithmsArea Under CurveBiopsy, Large-Core NeedleBreast NeoplasmsCarcinoma, Intraductal, NoninfiltratingFemaleHumansMiddle AgedNeoplasm InvasivenessNeoplasm StagingPreoperative PeriodRadiologybreast cancerductal carcinoma in situinvasive carcinomaMRIupstaging

Identifiers

PMID28181348
PMCPMC5910028
OpenAlexW2586330498

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.